Successful immunotherapy of canine flea allergy with injected Actinomycetales preparations

Immunotherapy

Volumn 3, Issue 8, 2011, Pages 971-978

  Marro, Alicia ^a   Pirles, Mnica ^a   Schiaffino, Laura ^a   Bin, Liliana ^a   Dvila, Héctor ^b   Bottasso, Oscar A ^b   McIntyre, Graham ^c   Ripley, Paul R ^c   Stanford, Cynthia A ^c,d   Stanford, John L ^c,d  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^c BioEos Ltd   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

actinomycetes; clinical improvement; flea allergy; pruritus

Indexed keywords

BE G 101; BE R 102; BE T 101; FIPRONIL; FRONTLINE; IMMUNOMODULATING AGENT; PLACEBO; PREDNISOLONE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ACTINOMYCETALES; ARTICLE; BACTERIUM CULTURE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE SEVERITY; DOG; DOG DISEASE; EOSINOPHIL COUNT; FEMALE; FLEA; FLEA INFESTATION; GORDONIA BRONCHIALIS; INSECT ALLERGY; MALE; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHODOCOCCUS COPROPHILUS; SINGLE DRUG DOSE; TSUKAMURELLA INCHONENSIS;

ACTINOMYCETALES; ALLERGENS; ANIMALS; CELL COUNT; DISEASE PROGRESSION; DOGS; EOSINOPHILS; HYPERSENSITIVITY; IMMUNOMODULATION; IMMUNOTHERAPY; PHARMACEUTICAL PREPARATIONS; SALIVA; SIPHONAPTERA; TH1-TH2 BALANCE;

EID: 80051883633     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.11.93     Document Type: Article

References (16)

1. Scott D, Miller W, Griffin C. Small Animal Dermatology (6th Edition).WB Saunders, PA, USA, 627-632 (2001).
2. McDermott MJ, Weber E, Hunter S et al. Identification, cloning, and characterisation of a major cat flea salivary allergen (Cte f 1).Mol. Immunol. 37(7), 361-375 (2000).
3. Halliwell RE, Preston JF, Nesbitt JG. Aspects of the immunopathogenesis of flea allergy dermatitis in dogs. Vet. Immunol. Immunopathol. 17(1-4), 483-494 (1987). (Pubitemid 18028231)
4. Wuersch K, Brachelente C, Doherr M et al. Immune dysregulation in flea allergy dermatitis - a model for the immunopathogenesis of allergic dermatitis. Vet. Immunol. Immunopathol. 110 (3-4), 311-323 (2006).
5. Stanford JL, Stanford CA, Grange JM. Environmental echoes. Sci. Prog. 84(Pt 2), 105-124 (2001).
6. Ricklin Gutzwiller ME, Reist M, Peel JE et al. Intradermal injection of heat-killed Mycobacterium vaccae in dogs with atopic dermatitis: a multicentre pilot study. Vet. Dermatol. 18(2), 87-93 (2007). (Pubitemid 46393258)
7. Olivry T, Marsella R, Iwasaki T et al. International task force on canine atopic dermatitis. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Vet. Dermatol. 18(2), 78-86 (2007). (Pubitemid 46393250)
8. Steffan J, Alexander D, Brovedani F et al. Comparison of cyclosporin A with methylprednisolone for treatment of canine atopic dermatitis: a parallel, blinded, randomised controlled trial. Vet. Dermatol. 14(1), 11-22 (2003). (Pubitemid 37248991)
9. Lund PA, Large AT, Kapatai G. The chaperonins: perspectives from the Archaea. Biochem. Soc. Trans. 31(Pt 3), 681-685 (2003). (Pubitemid 36750756)
10. Stanford JL, Stanford CA, Stansby G et al. The common mycobacterial antigens and their importance in the treatment of disease. Curr. Pharm. Des. 15(11), 1248-1260 (2009).
11. Camporota L, Corkhill A, Long H et al. The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma. Eur. Respir. J. 21(2), 287-293 (2003). (Pubitemid 36204544)
12. Rook GAW, Hernandez-Pando R, Dheda K, Teng Seah G. IL-4 in tuberculosis: implications for vaccine design. Trends Immunol. 25(9), 483-488 (2004). (Pubitemid 39490255)
13. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. Foxp3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10(7), 490-500 (2010).
14. Littlewood JD, O'Brien JK, Stanford JL et al. Management of Culicoides hypersensitivity (sweet-itch) in equids using killed bacterial preparation BE-T101: a randomised, double-blind, placebo-controlled study. Presented at: World Association of Veterinary Dermatology Congress 2008. Hong Kong, China, 19-22 November 2008.
15. Arkwright PD, David TJ. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J. Allergy Clin. Immunol. 107(3), 531-534 (2001). (Pubitemid 32210036)
16. Davies M, Symons C, Shaw S et al. An open study to assess the efficacy, clinically and immunologically, of M. vaccae vaccine in patients with atopic dermatitis. J. Dermatolog. Treat. 17(2), 74-77 (2006).